RSV AWARENESS & PREVENTION
WHAT ARE THE DANGERS?
Children under the age of 2 and the elderly are at the highest risk for the RSV virus, which contributes to over 240,000 hospitalizations annually, approximately 300 deaths in children under 2, and approximately 10,000 deaths in adults. Preliminary research indicates that RSV monoclonal antibodies can help approximately 80-90% of young children avoid hospitalization.
WHO IS ELIGIBLE TO RECEIVE THE RSV ANTIBODIES OR VACCINE?
Infants and young children, pregnant women between 32-36 weeks of gestation, individuals aged 75 years or older, and those aged 60-74 with an increased risk of severe RSV should get the either the antibody product called nirsevimab (Beyfortus) for babies or small children, the maternal RSV vaccine for pregnant women, or the adult RSV vaccine. The recommended timeframe for getting it coincides with receiving the flu vaccine (typically October through March).
Help someone you love to avoid being hospitalized — or worse. Get your children vaccinated for RSV and encourage your older friends and family to do the same. Please consult a FourPoints Health primary care provider with any questions you may have.